These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 17479951

  • 21. Human immunodeficiency virus-associated wasting and mechanisms of cachexia associated with inflammation.
    Moldawer LL, Sattler FR.
    Semin Oncol; 1998 Feb; 25(1 Suppl 1):73-81. PubMed ID: 9482543
    [Abstract] [Full Text] [Related]

  • 22. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

  • 23. Acute phase response and energy balance in stable human immunodeficiency virus-infected patients: a doubly labeled water study.
    Coors M, Süttmann U, Trimborn P, Ockenga J, Müller MJ, Selberg O.
    J Lab Clin Med; 2001 Aug; 138(2):94-100. PubMed ID: 11477375
    [Abstract] [Full Text] [Related]

  • 24. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
    Omland LH, Weis N, Skinhøj P, Laursen A, Christensen PB, Nielsen HI, Møller A, Engsig F, Sørensen HT, Obel N.
    HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
    [Abstract] [Full Text] [Related]

  • 25. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
    Tincati C, Biasin M, Bandera A, Violin M, Marchetti G, Piacentini L, Vago GL, Balotta C, Moroni M, Franzetti F, Clerici M, Gori A.
    Antivir Ther; 2009 May; 14(3):321-30. PubMed ID: 19474466
    [Abstract] [Full Text] [Related]

  • 26. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H, Zheng YH, Shen Z, Liu M, Liu C, He Y, Chen J, Ou QY, Huang ZL.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 13; 87(42):2973-6. PubMed ID: 18261327
    [Abstract] [Full Text] [Related]

  • 27. Update on HIV/HAART associated morphologic and metabolic abnormalities.
    Falutz J.
    Forum Nutr; 2003 Nov 13; 56():158-62. PubMed ID: 15806844
    [No Abstract] [Full Text] [Related]

  • 28. Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection.
    Samaras K.
    J Antimicrob Chemother; 2008 Feb 13; 61(2):238-45. PubMed ID: 18070830
    [Abstract] [Full Text] [Related]

  • 29. [Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].
    Ergünay K, Altinbaş A, Calik Başaran N, Unal S, Us D, Karabulut E, Ustaçelebi S.
    Mikrobiyol Bul; 2008 Jul 13; 42(3):413-9. PubMed ID: 18822884
    [Abstract] [Full Text] [Related]

  • 30. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.
    Zeitoun JD, Mallet V, Chaix ML, Viard JP, Blanche S, Pol S.
    J Clin Virol; 2007 Sep 13; 40(1):71-3. PubMed ID: 17658294
    [Abstract] [Full Text] [Related]

  • 31. Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome.
    Murdaca G, Contini P, Setti M, Cagnati P, Villa R, Lantieri F, Indiveri F, Puppo F.
    Hum Immunol; 2007 Nov 13; 68(11):894-900. PubMed ID: 18082568
    [Abstract] [Full Text] [Related]

  • 32. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A, Leti W, De Santis W, Marziali M, Esposito A, Fimiani C, Luzi G, Pinti M, Cossarizza A, Aiuti F, Mezzaroma I.
    Clin Infect Dis; 2008 Jun 15; 46(12):1902-10. PubMed ID: 18462177
    [Abstract] [Full Text] [Related]

  • 33. Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand.
    Puthanakit T, Aurpibul L, Oberdorfer P, Akarathum N, Kanjanavanit S, Wannarit P, Sirisanthana T, Sirisanthana V.
    Pediatr Infect Dis J; 2007 Oct 15; 26(10):953-6. PubMed ID: 17901804
    [Abstract] [Full Text] [Related]

  • 34. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
    Pippi F.
    Med Hypotheses; 2008 Oct 15; 70(2):291-3. PubMed ID: 17681707
    [Abstract] [Full Text] [Related]

  • 35. Body image is a major determinant of sexual dysfunction in stable HIV-infected women.
    Luzi K, Guaraldi G, Murri R, De Paola M, Orlando G, Squillace N, Esposito R, Rochira V, Zirilli L, Martinez E.
    Antivir Ther; 2009 Oct 15; 14(1):85-92. PubMed ID: 19320240
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
    Song R, Jelagat J, Dzombo D, Mwalimu M, Mandaliya K, Shikely K, Essajee S.
    Pediatrics; 2007 Oct 15; 120(4):e856-61. PubMed ID: 17846147
    [Abstract] [Full Text] [Related]

  • 37. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G, Porqueddu EM, Cambosu F, Saba F, Fois AG, Pirina P, Mura MS.
    Infection; 2008 Jun 15; 36(3):231-6. PubMed ID: 18463787
    [Abstract] [Full Text] [Related]

  • 38. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.
    Rall LC, Roubenoff R.
    Rheumatology (Oxford); 2004 Oct 15; 43(10):1219-23. PubMed ID: 15292530
    [Abstract] [Full Text] [Related]

  • 39. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
    Kuntzen T, Tural C, Li B, Feldmann G, Kupfer B, Nischalke HD, Clotet B, Sauerbruch T, Rockstroh JK, Spengler U.
    AIDS; 2008 Jan 11; 22(2):203-10. PubMed ID: 18097222
    [Abstract] [Full Text] [Related]

  • 40. The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.
    Gazzola L, Tincati C, Bellistrì GM, Monforte Ad, Marchetti G.
    Clin Infect Dis; 2009 Feb 01; 48(3):328-37. PubMed ID: 19123868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.